PDT Partners’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,239
Closed -$175K 918
2020
Q4
$175K Sell
1,239
-2,264
-65% -$334K 0.01% 619
2020
Q3
$574K Buy
3,503
+858
+32% +$153K 0.04% 414
2020
Q2
$547K Buy
2,645
+710
+37% +$165K 0.04% 395
2020
Q1
$386K Buy
1,935
+1,209
+167% +$265K 0.03% 431
2019
Q4
$152K Buy
+726
New +$104K 0.01% 670
2015
Q4
Sell
-1,314
Closed -$883K 1036
2015
Q3
$883K Buy
1,314
+197
+18% +$140K 0.02% 752
2015
Q2
$745K Buy
1,117
+692
+163% +$457K 0.02% 839
2015
Q1
$285K Buy
425
+358
+534% +$236K 0.01% 1173
2014
Q4
$35K Sell
67
-268
-80% -$134K ﹤0.01% 602
2014
Q3
$199K Hold
335
0.01% 1190
2014
Q2
$219K Buy
335
+120
+56% +$79.5K 0.01% 1298
2014
Q1
$169K Buy
215
+54
+34% +$43.9K ﹤0.01% 1249
2013
Q4
$124K Buy
+161
New +$121K 0.01% 607

Other funds holding MTEM

PDT Partners's MTEM Position: Q1 2021 in Review

PDT Partners sold out of Molecular Templates, Inc. (MTEM) in Q1 2021, closing a stake of 1,239 shares — an estimated $175K sold.

PDT Partners first reported a position in MTEM in Q4 2013 and held it in 13 quarters. The position peaked at $883K in Q3 2015. 102 funds tracked by Wall St. Rank hold MTEM as of Q1 2021.

  • PDT Partners reported no remaining Molecular Templates, Inc. position as of Q1 2021 after selling out during the quarter.
  • PDT Partners sold 1,239 Molecular Templates, Inc. shares in Q1 2021, an estimated $175K.
  • PDT Partners first reported a position in Molecular Templates, Inc. in Q4 2013 and held it in 13 quarters.
  • PDT Partners's Molecular Templates, Inc. position peaked at $883K in Q3 2015.
  • 102 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2021.

Based on PDT Partners's 13F filing for Q1 2021, filed 17 May 2021.